Document is current
Any future updates will be listed below
-
Authors
Elshaer, Sally L.
Evans, William
Pentecost, Mickey
Lenin, Raji
Periasamy, Ramesh
Jha, Kumar Abhiram
Alli, Shanta
Gentry, Jordy
Thomas, Samuel M.
Sohl, Nicolas
Gangaraju, Rajashekhar https://orcid.org/0000-0002-6664-8286
-
Funding
Funding for this research was provided by:
National Eye Institute (EY023427)
Research to Prevent Blindness (Hamilton Eye Institute)
- License Information
-
More Information
Article History
Received: 2 July 2018
Revised: 5 October 2018
Accepted: 23 October 2018
First Online: 21 November 2018
Ethics approval and consent to participate
: Studies involving human adipose tissue were approved by UTHSC Institutional Review Board in accordance with relevant guidelines and regulations following the tenets of the Declaration of Helsinki. Institutional IRB approved the study as an exempt since the study involved de-identified cell lines from commercial sources. Animal studies were approved by the Institutional Animal Care and Use Committee, University of Tennessee Health Sciences Center (UTHSC), following the guidelines as per the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research.
: Not applicable.
: NS and RG are co-founders and hold equity in Cell Care Therapeutics Inc., whose interest is in the use of adipose-derived stromal cells in visual disorders. MP is an employee of Cell Care Therapeutics Inc. with equity. None of the other authors declare any financial conflicts.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
